05.01.2005 20:22:00
|
Bausch & Lomb to Present at the 23rd Annual JP Morgan Healthcare Confe
Business Editors/Health/Medical Writers
JPMorgan Annual Healthcare Conference 2005
ROCHESTER, N.Y.--(BUSINESS WIRE)--Jan. 5, 2005--Bausch & Lomb (NYSE:BOL) announced today that Company management will present an overview of operations at the 23rd Annual JP Morgan Healthcare Conference in San Francisco on Wednesday, January 12, at 2:30 p.m. PT.
An audio replay of the presentation, as well as the presentation slides, will be available on the Investor Relations page of the Company's Web site, www.bausch.com, following the conference.
Bausch & Lomb is the eye health company, dedicated to perfecting vision and enhancing life for consumers around the world. Its core businesses include soft and rigid gas permeable contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products. The Bausch & Lomb name is one of the best known and most respected healthcare brands in the world. Founded in 1853 in Rochester, N.Y., where it continues to have its headquarters, the Company's 2003 revenues were $2 billion; it employs approximately 11,500 people worldwide and its products are available in more than 100 countries. More information about the Company can be found on the Bausch & Lomb Web site at www.bausch.com. Copyright Bausch & Lomb.
--30--SS/ny*
CONTACT: Bausch & Lomb News Media Contact: Margaret Graham, 585-338-5469 Margaret.Graham@Bausch.com or Investor Relations Contact: Daniel L. Ritz, 585-338-5802 Daniel.L.Ritz@bausch.com
KEYWORD: CALIFORNIA NEW YORK INDUSTRY KEYWORD: BANKING MEDICAL TRADESHOW PRODUCT SOURCE: Bausch & Lomb
Copyright Business Wire 2005
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bausch & Lomb Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Bausch & Lomb Inc.mehr Analysen
Indizes in diesem Artikel
S&P 500 | 5 827,04 | -1,54% |